UVM Cancer Center Investigators Publish the Breast Pre-Cancer Atlas

January 18, 2022 by Kate Strotmeyer

UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.

Gene expression in human breast cancer specimen analyzed by multi-spectral imaging.

As published in npj Breast Cancer, a Nature Portfolio publication, the pre-cancer atlas – a six-year, NCI-funded, collaborative initiative - establishes the molecular and cellular properties of early-stage breast cancer. By combining histological, molecular, and immunological profiling to provide risk markers for tumor progression, the groundbreaking research offers guidance for treatment or evidence-informed observation.

The paper, “The breast pre-cancer atlas illustrates the molecular and micro-environment diversity of ductal carcinoma in situ,” is co-authored by a team of six UVM Cancer Center investigators, Janet Stein, Ph.D., Donald Weaver, M.D., Gary Stein, Ph.D., Brian Sprague, Ph.D.,  Jonathan Gordon, Ph.D., and Mark Evans, Ph.D., who partnered with scientists and clinicians at the University of California San Francisco, the University of California Davis, and the University of California San Diego. 

Leveraging the power of recent methodological advances, the team characterized the mutational, transcriptional, histological, and micro-environment landscape of thirty-nine patient tumors to develop a multimodal breast pre-cancer atlas. 

The pre-cancer atlas combines parallel histological, molecular, and immunological profiling to provide risk markers for tumor progression and guidance for evidence-informed observation.

The breast pre-cancer atlas represents the expertise and experience of UVM Cancer Center scientists and physician investigators and the effective partnerships of cancer center members with colleagues who bring complimentary research and clinical capabilities. 

“The fabric of our Cancer Center is collaboration and the initiative reported in The breast pre-cancer atlas illustrates the molecular and micro-environment diversity of ductal carcinoma in situ illustrates a significant contribution that will be broadly relevant,” said Dr. Gary Stein, a co-investigator. 


We foster brilliant teachers, who educate talented students, who become the caring, knowledgeable physicians and scientists of tomorrow.


Join the 2024 MATCH DAY CHALLENGE

Your gift to the Larner College of Medicine unlocks big opportunities - including $30,000 in funds to support our students. Online donors of $100 or more receive a Dr. Moo tote bag while supplies last!

Match Challenge 24

Infographic about Match Day Challenge fundraiser

Events


 

Voices of the College

Two med students thumbs up

"I found myself volunteering in many youth programs throughout my life so far and each interaction has given me hope for the future." 
—Shubi Joshi, Class of 2025

"I loved the idea of bringing our Vermont and Connecticut communities together in a way that highlighted our commitment to service and sneakers."
–Mohamad Hamza, Class of 2024

Read latest blog post

Class of 2027  stats - 124 students, 26% Vermonters, 24% underrepresented in medicine, 24% LGBTQA Identified


Popular Links

Larner celebrates bicentennial

The Robert Larner, M.D. College of Medicine: A Medical Education Second to None